公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2016 | 135O_PR: Plasma genotyping for predicting benefit from osimertinib in patients (pts) with advanced NSCLC | Oxnard G.R; Thress K.S; Alden R.S; Lawrance R; Paweletz C.P; Cantarini M; Barrett C; CHIH-HSIN YANG ; Jänne P. | Journal of Thoracic Oncology | 9 | 8 | |
2016 | Association between plasma genotyping and outcomes of treatment with osimertinib (AZD9291) in advanced non-small-cell lung cancer | Oxnard G.R; Thress K.S; Alden R.S; Lawrance R; Paweletz C.P; Cantarini M; CHIH-HSIN YANG ; Barrett J.C; Jänne P.A. | Journal of Clinical Oncology | 710 | 633 |